Daily Mail: First new class of antibiotics to hit market in 40 years 20:13

GSK plans to market the antibiotic hepotidacin for the treatment of urinary tract infections unresponsive to current antibiotics. Reported by the Daily Mail.

Hepotidacin, which has been in development for over a decade, if approved, will become the first-class antibiotic produced in almost 40 years.

Symptoms of urinary tract infections include a burning pain when you go to the toilet more often than usual and feeling the need to go to the toilet when your bladder is empty. In elderly patients, the infection can cause a dementia-like condition called delirium. There is also the risk of sepsis, which causes about 50,000 deaths per year. Most often, infections develop in women, and modern antibiotics are often ineffective due to bacterial resistance to them.

Hepotidasine is expected to be used to treat a number of other diseases, including gonorrhea, which is considered one of the most treatment-resistant infections.

GSK, the pharmaceutical company that produces geopotidacin, plans to apply for US approval in the spring of 2023.

Source: Gazeta


More from author

Working Russians’ dream seaside holiday 03:00

In Russia, one in three women and only one in five men dream of a holiday by the sea. This was demonstrated by...

Saldo talked about how the Ukrainian Armed Forces acted in the direction of Kherson 03:17

Kherson Region Governor Vladimir Saldo said that the attempts of the Ukrainian Armed Forces to cross the Dnieper River were blocked by the Russian...

US says Ukraine’s defeat will lead to collapse of American world 03:26

Ukraine may suffer defeat in its match against Russia this summer. An American magazine columnist wrote about this National Review Andrew Stattaford. According to...

Russian hockey player was named the most valuable player of the NHL team 04/15/2024, 21:37

According to journalists, Russian hockey player Artemy Panarin was recognized as the most valuable player (MVP) of the National Hockey League (NHL) club "New...